New: Introducing the Finviz Crypto Map

Learn More
Last Close
Jul 18 04:00PM ET
23.58
Dollar change
-0.33
Percentage change
-1.37
%
CategoryUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y-3.48% Total Holdings70 Perf Week-0.94%
SponsorFidelity ETF Type Tagsequity Return% 3Y- AUM53.13M Perf Month0.88%
Fund Family Bond Type Tagstechnology Return% 5Y- NAV/sh Perf Quarter3.13%
Index- Average Maturity Tagsmedical Return% 10Y 52W High26.79 -12.00% Perf Half Y-6.87%
Index Weighting Commodity Type Tagsdisruptive Return% SI 52W Low20.69 13.95% Perf YTD-4.40%
Active/Passive Quant Type Tagsinnovation Flows% 1M0.00% Volatility1.28% 1.06% Perf Year-6.94%
Dividend TTM0.11 (0.48%) ESG Type Tags- Flows% 3M4.66% ATR (14)0.29 Perf 3Y-
Dividend Ex-DateDec 20, 2024 Dividend Type Sector/Theme Flows% YTD4.66% RSI (14)46.24 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta1.01 Perf 10Y-
Expense0.50% Growth/Value SMA20-1.00% Flows% 3Y Rel Volume0.89 Prev Close23.90
Inverse/Leveraged Market Cap SMA50-0.29% Flows% 5Y Avg Volume6.78K Price23.58
IPOJun 12, 2023 Option/ShortNo / Yes SMA200-4.71% Trades Volume6,043 Change-1.37%
Fidelity Disruptive Medicine ETF seeks long-term growth of capital. The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.